Related Experiment Video
Updated: Jan 18, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Identifying Adherence Trajectories in Chronic Hepatitis B: A Cluster-Based Approach to Long-Term Treatment Management
Lin Zhang1, Huichun Ji1, Suhua Pang1
1Department of Infectious Diseases, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
Insights
Medication adherence in chronic hepatitis B (CHB) patients shows varied patterns over time. Psychosocial factors like self-efficacy, social support, stigma, and depression significantly impact adherence, highlighting the need for targeted interventions.
Area of Science:
- Hepatology
- Psychology
- Public Health
Background:
- Chronic hepatitis B (CHB) requires long-term medication adherence for effective management.
- Understanding adherence patterns and influencing factors is crucial for treatment optimization.
Purpose of the Study:
- To investigate medication adherence levels and longitudinal trajectories in CHB patients.
- To identify key psychosocial factors affecting adherence.
- To provide evidence for strategies to improve adherence and quality of life.
Main Methods:
- Longitudinal study with 305 CHB patients over 12 months.
- Data collection on medication adherence and psychosocial factors at multiple time points.
- K-means cluster analysis to identify adherence patterns and associated psychosocial characteristics.
Main Results:
- Four distinct adherence trajectories were identified: improvement, low adherence, decline, and high adherence.
- Significant differences in adherence scores and psychosocial factors were observed across trajectories (p < 0.05).
- Higher adherence correlated with greater self-efficacy and social support; lower adherence linked to increased stigma and depression.
Conclusions:
- Medication adherence in CHB patients is dynamic and significantly influenced by psychosocial factors.
- Interventions targeting psychological support, stigma reduction, and social support networks are recommended.
- Improving adherence can enhance treatment outcomes and patient quality of life.
Abstract:
This study aimed to investigate the levels and longitudinal trajectories of medication adherence among patients with chronic hepatitis B (CHB), identify key psychosocial factors influencing adherence and provide evidence to inform strategies for optimising long-term treatment and enhancing patients' quality of life. A longitudinal study was conducted among CHB patients, 305 completing a 12-month follow-up. Medication adherence and psychosocial data were collected at baseline and at 3, 6, 9 and 12 months. K-means cluster analysis was performed to identify distinct adherence patterns, and differences in psychosocial characteristics across clusters were analysed. Four adherence trajectories were identified: improvement, low adherence, decline and high adherence. Significant differences were observed among the groups in terms of medication adherence scores and psychosocial factors (p < 0.05). Higher adherence was positively correlated with self-efficacy and social support, while lower adherence was associated with higher levels of perceived stigma and depression. Medication adherence among CHB patients exhibits distinct dynamic patterns, strongly influenced by psychosocial factors. Targeted interventions focusing on psychological support, stigma reduction and strengthening social support networks may improve adherence and ultimately enhance the quality of life for patients with chronic hepatitis B.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test